2nd Quarter - Report

JUUL LABS, INC. for JUUL LABS INC

Period 2nd Quarter 2019 Filed Jul 22, 2019 Signed by Jim R. Esquea

Official filing
Firm
JUUL LABS, INC.
Client
JUUL LABS INC
Income
—
Expenses
$1,010,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

HR 3164, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2020; provisions related to the FDA regulation of tobacco and vapor products, increasing the minimum age to purchase tobacco and vapor products, and counterfeit product detection and prevention of e-cigarettes and vapor products. Discussions related to the Senate Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2020; provisions related to the FDA regulation of tobacco and vapor products, increasing the minimum age to purchase tobacco and vapor products, and counterfeit product detection and prevention of e-cigarettes and vapor products

LobbyistCovered position, as disclosed
KAITLYN BOECKER —
BENJAMIN BRANCH Deputy LD, Rep. Albert Wynn, September 2003-March 2007; Senior Policy Advisor/LD, Rep. Gregory Meeks, October 2007-November 2013.
JIM R ESQUEA —
EDWARD DEAN MCCANN Assistant to the Speaker for Policy, Nov 2015-Aug 2018; Staff Dir. Soc. Sec. Subcommittee Jan 2015- Dec. 2015; Budget Analyst, House Budget Comm. May 2009-Dec. 2014; LC/LA/Office Administrator, Rep. Paul Ryan June 2006-May 2009.

Contacted: White House Office; SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3164 (116th)

Tobacco TOB

Regulation of e-cigarettes and vaping products designed to improve the lives of adult smokers; Supported proposals to prohibit the sale or distribution of tobacco products to individuals under the age of 21; H.R. 293, Youth Vaping Prevention Act of 2019; H.R. 1498/S. 655, SAFE Kids Act; H.R. 1642/S. 1965, Combating the Illicit Trade in Tobacco Products Act; H.R. 1897/S. 916, MOMMAs Act; provisions related to taxation of tobacco products; H.R. 2084, SCOTT Act of 2019; H.R. 2111/S. 1048, PROTECT Act; H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019; H.R. 2411/S. 1258, Tobacco to 21 Act; S. 616, E-cigarette Youth Protection Act; S. 1541, Tobacco Free Youth Act; S. 1895, Lower Health Care Costs Act; provisions related to the regulation of tobacco products

LobbyistCovered position, as disclosed
KAITLYN BOECKER —
BENJAMIN BRANCH Deputy LD, Rep. Albert Wynn, September 2003-March 2007; Senior Policy Advisor/LD, Rep. Gregory Meeks, October 2007-November 2013.
JIM R ESQUEA —
EDWARD DEAN MCCANN Assistant to the Speaker for Policy, Nov 2015-Aug 2018; Staff Dir. Soc. Sec. Subcommittee Jan 2015- Dec. 2015; Budget Analyst, House Budget Comm. May 2009-Dec. 2014; LC/LA/Office Administrator, Rep. Paul Ryan June 2006-May 2009.

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Office of Management & Budget (OMB); SENATE

Bills named: S. 916 (116th), S. 655 (116th), H.R. 2111 (116th), S. 1895 (116th), S. 1048 (116th), H.R. 2084 (116th), H.R. 1498 (116th), H.R. 293 (116th), S. 1965 (116th), S. 1258 (116th), S. 1541 (116th), S. 616 (116th), H.R. 2411 (116th), H.R. 2339 (116th), H.R. 1642 (116th), H.R. 1897 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.